• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-181b 通过靶向 LATS2 促进卵巢癌细胞生长和侵袭。

MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.

机构信息

Department of Gynecology, Huadong Hospital, Fudan University, 221 Yan'an West Road, Shanghai, China.

Department of Gynecology, Huadong Hospital, Fudan University, 221 Yan'an West Road, Shanghai, China.

出版信息

Biochem Biophys Res Commun. 2014 May 9;447(3):446-51. doi: 10.1016/j.bbrc.2014.04.027. Epub 2014 Apr 13.

DOI:10.1016/j.bbrc.2014.04.027
PMID:24735543
Abstract

MicroRNAs (miRNAs) are strongly implicated in tumorigenesis and metastasis. In this study, we showed significant upregulation of miR-181b in ovarian cancer tissues, compared with the normal ovarian counterparts. Forced expression of miR-181b led to remarkably enhanced proliferation and invasion of ovarian cancer cells while its knockdown induced significant suppression of these cellular events. The tumor suppressor gene, LATS2 (large tumor suppressor 2), was further identified as a novel direct target of miR-181b. Specifically, miR-181b bound directly to the 3'-untranslated region (UTR) of LATS2 and suppressed its expression. Restoration of LATS2 expression partially reversed the oncogenic effects of miR-181b. Our results indicate that miR-181b promotes proliferation and invasion by targeting LATS2 in ovarian cancer cells. These findings support the utility of miR-181b as a potential diagnostic and therapeutic target for ovarian cancer.

摘要

微小 RNA(miRNAs)在肿瘤发生和转移中起着重要作用。在这项研究中,我们发现卵巢癌组织中 miR-181b 的表达明显上调,与正常卵巢组织相比。强制表达 miR-181b 导致卵巢癌细胞的增殖和侵袭明显增强,而其敲低则显著抑制这些细胞事件。肿瘤抑制基因 LATS2(大肿瘤抑制因子 2)被进一步鉴定为 miR-181b 的一个新的直接靶基因。具体而言,miR-181b 直接结合到 LATS2 的 3'非翻译区(UTR)并抑制其表达。LATS2 表达的恢复部分逆转了 miR-181b 的致癌作用。我们的结果表明,miR-181b 通过靶向卵巢癌细胞中的 LATS2 促进增殖和侵袭。这些发现支持 miR-181b 作为卵巢癌潜在诊断和治疗靶点的应用。

相似文献

1
MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.微小 RNA-181b 通过靶向 LATS2 促进卵巢癌细胞生长和侵袭。
Biochem Biophys Res Commun. 2014 May 9;447(3):446-51. doi: 10.1016/j.bbrc.2014.04.027. Epub 2014 Apr 13.
2
miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.在乳腺癌中上调的miR-135b通过调节LATS2促进细胞生长并扰乱细胞周期。
Int J Oncol. 2016 May;48(5):1997-2006. doi: 10.3892/ijo.2016.3405. Epub 2016 Feb 22.
3
Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.microRNA-187 通过靶向Disabled 同源物-2 调控卵巢癌进展。
Oncogene. 2012 Feb 9;31(6):764-75. doi: 10.1038/onc.2011.269. Epub 2011 Jul 4.
4
MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.微小RNA-25通过靶向大肿瘤抑制因子2促进卵巢癌的增殖和迁移。
Tumour Biol. 2014 Dec;35(12):12339-44. doi: 10.1007/s13277-014-2546-0. Epub 2014 Sep 2.
5
MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.微小RNA-373(miR-373)在转录后水平调控大肿瘤抑制因子同源物2(LATS2),并促进人食管癌的增殖。
Exp Cell Res. 2009 Sep 10;315(15):2529-38. doi: 10.1016/j.yexcr.2009.06.001. Epub 2009 Jun 6.
6
MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.微小 RNA-155 是一种新型的卵巢癌起始细胞的抑制剂,其靶标是 CLDN1。
FEBS Lett. 2013 May 2;587(9):1434-9. doi: 10.1016/j.febslet.2013.03.023. Epub 2013 Mar 20.
7
MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2.微小RNA-195通过靶向大肿瘤抑制因子2调控人肝癌细胞的细胞凋亡。
Pharmazie. 2012 Jul;67(7):645-51.
8
MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.miR-145 在人卵巢癌中下调,并通过靶向 p70S6K1 和 MUC1 调节细胞生长和侵袭。
Biochem Biophys Res Commun. 2013 Nov 29;441(4):693-700. doi: 10.1016/j.bbrc.2013.10.053. Epub 2013 Oct 21.
9
MiR-718 represses VEGF and inhibits ovarian cancer cell progression.miR-718 抑制 VEGF 并抑制卵巢癌细胞的进展。
FEBS Lett. 2014 Jun 5;588(12):2078-86. doi: 10.1016/j.febslet.2014.04.040. Epub 2014 May 8.
10
miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.miR-9 通过靶向 TLN1 在卵巢浆液性癌中发挥肿瘤抑制作用。
Int J Mol Med. 2013 Aug;32(2):381-8. doi: 10.3892/ijmm.2013.1400. Epub 2013 May 30.

引用本文的文献

1
Cancer and Alzheimer's Inverse Correlation: an Immunogenetic Analysis.癌症与老年痴呆症呈负相关:免疫遗传学分析。
Mol Neurobiol. 2023 Jun;60(6):3086-3099. doi: 10.1007/s12035-023-03260-8. Epub 2023 Feb 16.
2
EPDR1, Which Is Negatively Regulated by miR-429, Suppresses Epithelial Ovarian Cancer Progression PI3K/AKT Signaling Pathway.受miR-429负调控的EPDR1通过PI3K/AKT信号通路抑制上皮性卵巢癌进展。
Front Oncol. 2021 Dec 23;11:751567. doi: 10.3389/fonc.2021.751567. eCollection 2021.
3
miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway.
miR-181b-5p 通过靶向 PARK2 经 PTEN/PI3K/AKT 信号通路促进胆管癌的进展。
Biochem Genet. 2022 Feb;60(1):223-240. doi: 10.1007/s10528-021-10084-5. Epub 2021 Jun 24.
4
Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21.顺式阿曲库铵通过促进 lincRNA-p21 抑制卵巢癌细胞的生长并诱导其凋亡。
Bioengineered. 2021 Dec;12(1):1505-1516. doi: 10.1080/21655979.2021.1916271.
5
Long non‑coding RNA suppresses ovarian cancer progression by regulating Hippo/YAP signaling.长链非编码 RNA 通过调控 Hippo/YAP 信号通路抑制卵巢癌细胞的进展。
Int J Mol Med. 2021 Apr;47(4). doi: 10.3892/ijmm.2021.4877. Epub 2021 Feb 12.
6
The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.微小 RNA 在卵巢上皮性癌转移中的作用。
Int J Mol Sci. 2020 Sep 25;21(19):7093. doi: 10.3390/ijms21197093.
7
Downregulation of miR‑181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF‑κB signaling pathway.下调 miR-181b 通过靶向 CYLD 抑制 NF-κB 信号通路抑制人结肠癌细胞增殖。
Int J Mol Med. 2020 Nov;46(5):1755-1764. doi: 10.3892/ijmm.2020.4720. Epub 2020 Sep 4.
8
MicroRNA-181b blocks gensenoside Rg3-mediated tumor suppression of gallbladder carcinoma by promoting autophagy flux via CREBRF/CREB3 pathway.微小RNA-181b通过CREBRF/CREB3途径促进自噬通量,从而阻断人参皂苷Rg3介导的胆囊癌肿瘤抑制作用。
Am J Transl Res. 2019 Sep 15;11(9):5776-5787. eCollection 2019.
9
FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer.FOXC1对miR-31-5p的调控通过靶向LATS2赋予结直肠癌对奥沙利铂的抗性。
Cancers (Basel). 2019 Oct 16;11(10):1576. doi: 10.3390/cancers11101576.
10
miR-181a/b therapy in lung cancer: reality or myth?miR-181a/b 治疗肺癌:现实还是神话?
Mol Oncol. 2019 Jan;13(1):9-25. doi: 10.1002/1878-0261.12420. Epub 2019 Jan 3.